SEC Form 4 · accession 0001437749-16-043421
GeoVax Labs, Inc. · GOVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Reynolds
Officer — CFO
Period of report
Dec 13, 2016
Accepted (ET)
Dec 15, 2016 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000832489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $0.0652 | Dec 13, 2016 | A | 335,000 | A | — | Dec 13, 2026 | Common Stock | 335,000 | 335,000 | D |
Explanation of responses
- F1Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.